Literature DB >> 20349096

RNA processing pathways in amyotrophic lateral sclerosis.

Marka van Blitterswijk1, John E Landers.   

Abstract

RNA processing is a tightly regulated, highly complex pathway which includes RNA transcription, pre-mRNA splicing, editing, transportation, translation, and degradation of RNA. Over the past few years, several RNA processing genes have been shown to be mutated or genetically associated with amyotrophic lateral sclerosis (ALS), including the RNA-binding proteins TDP-43 and FUS/TLS. These findings suggest that RNA processing may represent a common pathogenic mechanism involved in development of ALS. In this review, we will discuss six ALS-related, RNA processing genes including their discovery, function, and commonalities.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20349096     DOI: 10.1007/s10048-010-0239-4

Source DB:  PubMed          Journal:  Neurogenetics        ISSN: 1364-6745            Impact factor:   2.660


  243 in total

Review 1.  Stirring up development with the heterotrimeric kinesin KIF3.

Authors:  N Hirokawa
Journal:  Traffic       Date:  2000-01       Impact factor: 6.215

Review 2.  RNA oxidation: a contributing factor or an epiphenomenon in the process of neurodegeneration.

Authors:  Qiongman Kong; Xiu Shan; Yueming Chang; Hirofumi Tashiro; Chien-Liang Glenn Lin
Journal:  Free Radic Res       Date:  2008-09

3.  Angiogenin protects motoneurons against hypoxic injury.

Authors:  J Sebastià; D Kieran; B Breen; M A King; D F Netteland; D Joyce; S F Fitzpatrick; C T Taylor; J H M Prehn
Journal:  Cell Death Differ       Date:  2009-05-15       Impact factor: 15.828

4.  Cytoplasmic mislocalization of TDP-43 is toxic to neurons and enhanced by a mutation associated with familial amyotrophic lateral sclerosis.

Authors:  Sami J Barmada; Gaia Skibinski; Erica Korb; Elizabeth J Rao; Jane Y Wu; Steven Finkbeiner
Journal:  J Neurosci       Date:  2010-01-13       Impact factor: 6.167

5.  Control of motoneuron survival by angiogenin.

Authors:  Dairín Kieran; Jordi Sebastia; Matthew J Greenway; Matthew A King; Dervla Connaughton; Caoimhin G Concannon; Beau Fenner; Orla Hardiman; Jochen H M Prehn
Journal:  J Neurosci       Date:  2008-12-24       Impact factor: 6.167

6.  Co-morbidity of TDP-43 proteinopathy in Lewy body related diseases.

Authors:  Hanae Nakashima-Yasuda; Kunihiro Uryu; John Robinson; Sharon X Xie; Howard Hurtig; John E Duda; Steven E Arnold; Andrew Siderowf; Murray Grossman; James B Leverenz; Randy Woltjer; Oscar L Lopez; Ronald Hamilton; Debby W Tsuang; Douglas Galasko; Eliezer Masliah; Jeffrey Kaye; Christopher M Clark; Thomas J Montine; Virginia M-Y Lee; John Q Trojanowski
Journal:  Acta Neuropathol       Date:  2007-07-25       Impact factor: 17.088

7.  The widespread expression of angiogenin in different human cells suggests a biological function not only related to angiogenesis.

Authors:  M Moenner; M Gusse; E Hatzi; J Badet
Journal:  Eur J Biochem       Date:  1994-12-01

8.  Variants of the elongator protein 3 (ELP3) gene are associated with motor neuron degeneration.

Authors:  Claire L Simpson; Robin Lemmens; Katarzyna Miskiewicz; Wendy J Broom; Valerie K Hansen; Paul W J van Vught; John E Landers; Peter Sapp; Ludo Van Den Bosch; Joanne Knight; Benjamin M Neale; Martin R Turner; Jan H Veldink; Roel A Ophoff; Vineeta B Tripathi; Ana Beleza; Meera N Shah; Petroula Proitsi; Annelies Van Hoecke; Peter Carmeliet; H Robert Horvitz; P Nigel Leigh; Christopher E Shaw; Leonard H van den Berg; Pak C Sham; John F Powell; Patrik Verstreken; Robert H Brown; Wim Robberecht; Ammar Al-Chalabi
Journal:  Hum Mol Genet       Date:  2008-11-07       Impact factor: 6.150

9.  Functional mapping of the interaction between TDP-43 and hnRNP A2 in vivo.

Authors:  Andrea D'Ambrogio; Emanuele Buratti; Cristiana Stuani; Corrado Guarnaccia; Maurizio Romano; Youhna M Ayala; Francisco E Baralle
Journal:  Nucleic Acids Res       Date:  2009-05-08       Impact factor: 16.971

10.  Reduced expression of the Kinesin-Associated Protein 3 (KIFAP3) gene increases survival in sporadic amyotrophic lateral sclerosis.

Authors:  John E Landers; Judith Melki; Vincent Meininger; Jonathan D Glass; Leonard H van den Berg; Michael A van Es; Peter C Sapp; Paul W J van Vught; Diane M McKenna-Yasek; Hylke M Blauw; Ting-Jan Cho; Meraida Polak; Lijia Shi; Anne-Marie Wills; Wendy J Broom; Nicola Ticozzi; Vincenzo Silani; Aslihan Ozoguz; Ildefonso Rodriguez-Leyva; Jan H Veldink; Adrian J Ivinson; Christiaan G J Saris; Betsy A Hosler; Alayna Barnes-Nessa; Nicole Couture; John H J Wokke; Thomas J Kwiatkowski; Roel A Ophoff; Simon Cronin; Orla Hardiman; Frank P Diekstra; P Nigel Leigh; Christopher E Shaw; Claire L Simpson; Valerie K Hansen; John F Powell; Philippe Corcia; François Salachas; Simon Heath; Pilar Galan; Franck Georges; H Robert Horvitz; Mark Lathrop; Shaun Purcell; Ammar Al-Chalabi; Robert H Brown
Journal:  Proc Natl Acad Sci U S A       Date:  2009-05-18       Impact factor: 11.205

View more
  31 in total

1.  Rare Angiogenin and Ribonuclease 4 variants associated with amyotrophic lateral sclerosis exhibit loss-of-function: a comprehensive in silico study.

Authors:  Aditya K Padhi; Priyam Narain; James Gomes
Journal:  Metab Brain Dis       Date:  2019-07-31       Impact factor: 3.584

2.  The ALS-associated proteins FUS and TDP-43 function together to affect Drosophila locomotion and life span.

Authors:  Ji-Wu Wang; Jonathan R Brent; Andrew Tomlinson; Neil A Shneider; Brian D McCabe
Journal:  J Clin Invest       Date:  2011-09-01       Impact factor: 14.808

3.  TDP-43 and FUS RNA-binding proteins bind distinct sets of cytoplasmic messenger RNAs and differently regulate their post-transcriptional fate in motoneuron-like cells.

Authors:  Claudia Colombrita; Elisa Onesto; Francesca Megiorni; Antonio Pizzuti; Francisco E Baralle; Emanuele Buratti; Vincenzo Silani; Antonia Ratti
Journal:  J Biol Chem       Date:  2012-03-16       Impact factor: 5.157

4.  Ribonuclease 4 protects neuron degeneration by promoting angiogenesis, neurogenesis, and neuronal survival under stress.

Authors:  Shuping Li; Jinghao Sheng; Jamie K Hu; Wenhao Yu; Hiroko Kishikawa; Miaofen G Hu; Kaori Shima; David Wu; Zhengping Xu; Winnie Xin; Katherine B Sims; John E Landers; Robert H Brown; Guo-fu Hu
Journal:  Angiogenesis       Date:  2012-11-10       Impact factor: 9.596

5.  Nuclear localization of human SOD1 and mutant SOD1-specific disruption of survival motor neuron protein complex in transgenic amyotrophic lateral sclerosis mice.

Authors:  Barry Gertz; Margaret Wong; Lee J Martin
Journal:  J Neuropathol Exp Neurol       Date:  2012-02       Impact factor: 3.685

Review 6.  Cerebrovascular disorders: molecular insights and therapeutic opportunities.

Authors:  Erik Storkebaum; Annelies Quaegebeur; Miikka Vikkula; Peter Carmeliet
Journal:  Nat Neurosci       Date:  2011-10-26       Impact factor: 24.884

7.  Cytoplasmic sequestration of FUS/TLS associated with ALS alters histone marks through loss of nuclear protein arginine methyltransferase 1.

Authors:  Michael Tibshirani; Miranda L Tradewell; Katie R Mattina; Sandra Minotti; Wencheng Yang; Hongru Zhou; Michael J Strong; Lawrence J Hayward; Heather D Durham
Journal:  Hum Mol Genet       Date:  2014-09-30       Impact factor: 6.150

Review 8.  TDP-43 autoregulation: implications for disease.

Authors:  Mauricio Budini; Emanuele Buratti
Journal:  J Mol Neurosci       Date:  2011-06-18       Impact factor: 3.444

Review 9.  Targeting intrinsically disordered proteins in neurodegenerative and protein dysfunction diseases: another illustration of the D(2) concept.

Authors:  Vladimir N Uversky
Journal:  Expert Rev Proteomics       Date:  2010-08       Impact factor: 3.940

Review 10.  Common pathways of autoimmune inflammatory myopathies and genetic neuromuscular disorders.

Authors:  Minoru Satoh; Angela Ceribelli; Edward K L Chan
Journal:  Clin Rev Allergy Immunol       Date:  2012-02       Impact factor: 8.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.